However, if the mechanism of poor prognosis in CTNNB1 mutated ACC cases is elucidated in the future, the pathogenesis of ACC will be clarified, and the development of personalized ACC medicine can be expected to advance. The gene discussed is CTNNB1; the disease is adrenal cortex carcinoma.